iBio
IBIO
#10296
Rank
NZ$93.35 M
Marketcap
NZ$1.32
Share price
-4.00%
Change (1 day)
-31.57%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): NZ-$1.31

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$1.36. In 2025 the company made an earnings per share (EPS) of NZ-$3.17 an increase over its 2024 EPS that were of NZ-$11.77.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.31-58.55%
2025NZ-$3.17-73.08%
2024NZ-$11.77-93.88%
2023NZ-$192.29-8.14%
2022NZ-$209.3392.67%
2021NZ-$108.65-80.33%
2020NZ-$552.29-35.11%
2019NZ-$851.08-38.96%
2018NZ-$1,394-6.1%
2017NZ-$1,48536.67%
2016NZ-$1,08633.33%
2015NZ-$814.8650%
2014NZ-$543.24-53.85%
2013NZ-$1,177-7.14%
2012NZ-$1,268-64.1%
2011NZ-$3,53177.27%
2010NZ-$1,992144.44%
2009NZ-$814.8612.93%
2008NZ-$721.5812.2%
2007NZ-$643.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.10-990.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ-$0.94-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$12.13 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$9.13 572.00%๐Ÿ‡บ๐Ÿ‡ธ USA